As of 19 November 2025, the Health Technology Assessment Council has completed the evidence appraisal on the assessment of Thermal Ablation for the treatment of premalignant lesions of the cervix among women 30 to 65 years old who are deemed eligible for ablation in accordance to the World Health Organization (WHO) screen-treat approach or screen-triage-treat continue reading : HTA Council Preliminary Recommendation on Thermal Ablation for the Treatment of Premalignant Lesions of the Cervix among Women 30 to 65 years old
HTA Council Preliminary Recommendation on Moderate Complexity Nucleic Acid Amplification Tests (NAAT) for the Diagnosis of Multi-drug Resistant Tuberculosis (MDR-TB) with Simultaneous Isoniazid and Rifampicin Resistance Testing
As of 28 October 2025, the Health Technology Assessment Council has completed the evidence appraisal on the assessment of moderate complexity nucleic acid amplification tests (NAATs) for the diagnosis multi-drug resistant tuberculosis (MDR-TB) with simultaneous isoniazid (INH) and rifampicin (Rif) resistance testing for possible government financing. The HTA Council hereby releases its preliminary recommendation on continue reading : HTA Council Preliminary Recommendation on Moderate Complexity Nucleic Acid Amplification Tests (NAAT) for the Diagnosis of Multi-drug Resistant Tuberculosis (MDR-TB) with Simultaneous Isoniazid and Rifampicin Resistance Testing